Cochlear has been ordered by the U.S. District Court to pay USD 268 million in damages to the Alfred E. Mann Foundation for Scientific Research and Advanced Bionics due to patent infringement.
Almost two weeks after Cochlear’s (ASX:COH) brutal earnings downgrade investors are still struggling with a fundamental issue. The seminal question? Whether the performance erosion of one of our most ...
Wide-moat Cochlear withdrew fiscal 2020 profit guidance on the back of expected major declines in elective surgeries worldwide as hospital space gets prioritised to deal with COVID-19 patients. Given ...